Form 4 for CRL Charles River Laboratories
Accepted 2024-03-04 00:00:00 ET · period of report 2024-02-29 · accession 0001127602-24-008113 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-04 | 2024-02-29 | CRL | Parisotto Shannon M | CEVP, Disc, Safety Assessment | S - Sale | $253.45 | -3,786 | 4,792 | -44% | -$959.5K |
| I | 2024-03-04 | 2024-03-01 | CRL | Parisotto Shannon M | CEVP, Disc, Safety Assessment | G - Gift | $0.00 | -412 | 26.6K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-29 | S | D | 100 | $254.02 | 7,132 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-01 | G | D | 412 | $0.00 | 26,554 | I | — | — | (F2) Reflects the exempt transfer pursuant to Rule 16a-13 of 2,440 shares held by Karpathos Investments LLC to the reporting person. |
| 3 | Common | Common Stock | 2024-02-29 | S | D | 3,686 | $253.43 | 4,792 | D by Karpathos Investments LLC | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $252.99 to $253.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |